Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- N/A
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- Status
- RECRUITING
- Phase
- PHASE2
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Kesimpta (Ofatumumab) Pregnancy Registry
- Status
- RECRUITING
- Phase
- N/A
Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.
- Status
- COMPLETED
- Phase
- PHASE3
The 'Wearing Off' Effect of DMT
- Status
- COMPLETED
- Phase
- N/A
Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
- Status
- COMPLETED
- Phase
- N/A
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
- Status
- RECRUITING
- Phase
- N/A
French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients
- Status
- COMPLETED
- Phase
- N/A
Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure
- Status
- COMPLETED
- Phase
- N/A
Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden
- Status
- COMPLETED
- Phase
- N/A
Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1